封面
市场调查报告书
商品编码
1412405

葡萄糖胺市场:按类型、形状、产地、应用、配销通路- 2024-2030 年全球预测

Glucosamine Market by Types (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride), Form (Capsules, Liquid, Powder), Source, Application, Distribution Channel - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年葡萄糖胺市场规模为8.048亿美元,预计2024年将达8.4171亿美元,2030年将达11.4762亿美元,复合年增长率为5.28%。

葡萄糖胺的全球市场

主要市场统计
基准年[2023] 80048万美元
预测年份 [2024] 84171万美元
预测年份 [2030] 1,147.62 百万美元
复合年增长率(%) 5.28%
葡萄糖胺市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估葡萄糖胺市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市场占有率分析

市场占有率分析是一种综合工具,可以对葡萄糖胺市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵考察,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略,从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解:

1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。

3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题:

1-葡萄糖胺市场的市场规模和预测是多少?

2-在葡萄糖胺市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?

3-葡萄糖胺市场的技术趋势和法律规范是什么?

4-葡萄糖胺市场主要供应商的市场占有率是多少?

5-进入葡萄糖胺市场合适的型态和策略手段是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肥胖人口增加和关节炎病例增加
      • 骨骼和关节保健补充食品中葡萄糖胺的使用增加
      • 治疗有症状的膝骨关节炎对葡萄糖胺的需求不断增长
    • 抑制因素
      • 与葡萄糖胺产品相关的高成本
    • 机会
      • 葡萄糖胺新产品的上市与核准
      • 製造商专注于葡萄糖胺领域的研发活动
    • 任务
      • 与葡萄糖胺相关的一些副作用
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章葡萄糖胺市场:依类型

  • 盐酸盐葡萄糖胺
  • 葡萄糖胺硫酸盐氯化钾
  • 葡萄糖胺硫酸钠 氯化钠
  • N-乙酰葡萄糖胺

第七章葡萄糖胺市场:依形状分类

  • 胶囊
  • 液体
  • 粉末
  • 药片

第八章葡萄糖胺市场:依来源分类

  • 动物
    • 螃蟹
    • 龙虾
  • 植物
    • 玉米

第九章葡萄糖胺市场:依应用分类

  • 化妆品
  • 营养补充食品
  • 健康食品
  • 药品
  • 老兵专用医药

第10章葡萄糖胺市场:按配销通路

  • 网路商店
  • 药局
  • 零售店
  • 超级市场

第十一章美洲葡萄糖胺市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太葡萄糖胺市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的葡萄糖胺市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析:主要企业
  • 主要企业竞争情境分析

第15章竞争组合

  • 主要公司简介
    • Aden Healthcare
    • Andra Medi Pharma India Pvt. Ltd.
    • Bio-gen Extracts Pvt. Ltd.
    • Captek Softgel International Inc.
    • Cargill, Inc.
    • Cellmark AB
    • Enomark Pharma
    • Ethical Naturals Inc.
    • Fabrichem, Inc.
    • Fermentis Life Sciences
    • GlucosaGreen
    • Golden Shell Pharmaceutical Co. Ltd.
    • Kabir Lifesciences
    • Koyo Chemical Co., Ltd.
    • Lifecare Neuro Products Limited
    • Manus Aktteva Biopharma LLP
    • Panvo Organics Pvt Ltd.
    • Pax Healthcare
    • Schiff Nutrition International Inc.
    • SMPNutra
    • Spectrum Chemical Manufacturing Corp.
    • TSI Health Sciences, Inc.
    • United Laboratories, Inc.
    • Velnex Medicare
    • Wellable Marine Biotech Holding Limited
    • Zhejiang AOXING Biotechnology Co., Ltd.
  • 主要产品系列

第十六章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-C002B1C99525

[188 Pages Report] The Glucosamine Market size was estimated at USD 800.48 million in 2023 and expected to reach USD 841.71 million in 2024, at a CAGR 5.28% to reach USD 1,147.62 million by 2030.

Global Glucosamine Market

KEY MARKET STATISTICS
Base Year [2023] USD 800.48 million
Estimated Year [2024] USD 841.71 million
Forecast Year [2030] USD 1,147.62 million
CAGR (%) 5.28%
Glucosamine Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Glucosamine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Glucosamine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Glucosamine Market, highlighting leading vendors and their innovative profiles. These include Aden Healthcare, Andra Medi Pharma India Pvt. Ltd., Bio-gen Extracts Pvt. Ltd., Captek Softgel International Inc., Cargill, Inc., Cellmark AB, Enomark Pharma, Ethical Naturals Inc., Fabrichem, Inc., Fermentis Life Sciences, GlucosaGreen, Golden Shell Pharmaceutical Co. Ltd., Kabir Lifesciences, Koyo Chemical Co., Ltd., Lifecare Neuro Products Limited, Manus Aktteva Biopharma LLP, Panvo Organics Pvt Ltd., Pax Healthcare, Schiff Nutrition International Inc., SMPNutra, Spectrum Chemical Manufacturing Corp., TSI Health Sciences, Inc., United Laboratories, Inc., Velnex Medicare, Wellable Marine Biotech Holding Limited, and Zhejiang AOXING Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Glucosamine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Types
    • Glucosamine Hydrochloride
    • Glucosamine Sulfate Potassium Chloride
    • Glucosamine Sulfate Sodium Chloride
    • N-Acetylglucosamine
  • Form
    • Capsules
    • Liquid
    • Powder
    • Tablets
  • Source
    • Animal
      • Crab
      • Lobster
      • Shrimp
    • Plant
      • Corn
      • Mushrooom
  • Application
    • Cosmetics
    • Dietary Supplements
    • Health Food
    • Medicine
    • Veterinary
  • Distribution Channel
    • Online Stores
    • Pharmacies
    • Retail Stores
    • Supermarkets
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Glucosamine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Glucosamine Market?

3. What are the technology trends and regulatory frameworks in the Glucosamine Market?

4. What is the market share of the leading vendors in the Glucosamine Market?

5. Which modes and strategic moves are suitable for entering the Glucosamine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Glucosamine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing obese population coupled with increasing number of arthritis cases
      • 5.1.1.2. Increasing use of glucosamine in bone and joint health supplements
      • 5.1.1.3. Rising need for glucosamine for the treatment of symptomatic osteoarthritis of the knee
    • 5.1.2. Restraints
      • 5.1.2.1. High cost related to glucosamine products
    • 5.1.3. Opportunities
      • 5.1.3.1. Launch and approval of novel glucosamine products
      • 5.1.3.2. Focus of manufacturers on R&D activities in the field of glucosamine
    • 5.1.4. Challenges
      • 5.1.4.1. Several side effects associated with glucosamine
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Glucosamine Market, by Types

  • 6.1. Introduction
  • 6.2. Glucosamine Hydrochloride
  • 6.3. Glucosamine Sulfate Potassium Chloride
  • 6.4. Glucosamine Sulfate Sodium Chloride
  • 6.5. N-Acetylglucosamine

7. Glucosamine Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Liquid
  • 7.4. Powder
  • 7.5. Tablets

8. Glucosamine Market, by Source

  • 8.1. Introduction
  • 8.2. Animal
    • 8.3.1. Crab
    • 8.3.2. Lobster
    • 8.3.3. Shrimp
  • 8.3. Plant
    • 8.4.1. Corn
    • 8.4.2. Mushrooom

9. Glucosamine Market, by Application

  • 9.1. Introduction
  • 9.2. Cosmetics
  • 9.3. Dietary Supplements
  • 9.4. Health Food
  • 9.5. Medicine
  • 9.6. Veterinary

10. Glucosamine Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Online Stores
  • 10.3. Pharmacies
  • 10.4. Retail Stores
  • 10.5. Supermarkets

11. Americas Glucosamine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Glucosamine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Glucosamine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Aden Healthcare
    • 15.1.2. Andra Medi Pharma India Pvt. Ltd.
    • 15.1.3. Bio-gen Extracts Pvt. Ltd.
    • 15.1.4. Captek Softgel International Inc.
    • 15.1.5. Cargill, Inc.
    • 15.1.6. Cellmark AB
    • 15.1.7. Enomark Pharma
    • 15.1.8. Ethical Naturals Inc.
    • 15.1.9. Fabrichem, Inc.
    • 15.1.10. Fermentis Life Sciences
    • 15.1.11. GlucosaGreen
    • 15.1.12. Golden Shell Pharmaceutical Co. Ltd.
    • 15.1.13. Kabir Lifesciences
    • 15.1.14. Koyo Chemical Co., Ltd.
    • 15.1.15. Lifecare Neuro Products Limited
    • 15.1.16. Manus Aktteva Biopharma LLP
    • 15.1.17. Panvo Organics Pvt Ltd.
    • 15.1.18. Pax Healthcare
    • 15.1.19. Schiff Nutrition International Inc.
    • 15.1.20. SMPNutra
    • 15.1.21. Spectrum Chemical Manufacturing Corp.
    • 15.1.22. TSI Health Sciences, Inc.
    • 15.1.23. United Laboratories, Inc.
    • 15.1.24. Velnex Medicare
    • 15.1.25. Wellable Marine Biotech Holding Limited
    • 15.1.26. Zhejiang AOXING Biotechnology Co., Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLUCOSAMINE MARKET RESEARCH PROCESS
  • FIGURE 2. GLUCOSAMINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLUCOSAMINE MARKET DYNAMICS
  • FIGURE 7. GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2030 (%)
  • FIGURE 8. GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 10. GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 12. GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. GLUCOSAMINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 6. GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE POTASSIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE SODIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLUCOSAMINE MARKET SIZE, BY N-ACETYLGLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLUCOSAMINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLUCOSAMINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLUCOSAMINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLUCOSAMINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 16. GLUCOSAMINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 18. GLUCOSAMINE MARKET SIZE, BY CRAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLUCOSAMINE MARKET SIZE, BY LOBSTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLUCOSAMINE MARKET SIZE, BY SHRIMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLUCOSAMINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 23. GLUCOSAMINE MARKET SIZE, BY CORN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLUCOSAMINE MARKET SIZE, BY MUSHROOOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLUCOSAMINE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLUCOSAMINE MARKET SIZE, BY HEALTH FOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLUCOSAMINE MARKET SIZE, BY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLUCOSAMINE MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. GLUCOSAMINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLUCOSAMINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLUCOSAMINE MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLUCOSAMINE MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 327. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 328. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 329. GLUCOSAMINE MARKET LICENSE & PRICING